Trade CTY stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
City Therapeutics, Inc. (CTY) is trading at US$20.27, down 0.81% today as of Oct 22, 12:17 EDT. The company has a market capitalisation of US$956.31M. Over the past 52 weeks, CTY has traded between US$19.00 and US$23.88. On Syfe you can trade CTY with $0 commission and add it to your watchlist.
| Previous close | US$20.43 |
|---|---|
| Market cap | US$956.31M |
| 52-week range | US$19.00 – US$23.88 |
| Volume | 283.07K |
| Exchange | US |
City Therapeutics, Inc.
City Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the development of RNAi therapeutics. The company was founded by John Maraganore, Sebastian Trousil, Ari Nowacek, Mark Keating, Kotaro Nakanishi, Yukihide Tomari, and Phillip Zamore on July 17, 2023 and is headquartered in Cambridge, MA.
City Therapeutics, Inc. (CTY) stock is trading at US$20.27, -0.81% from the previous close of US$20.43.
The market cap for City Therapeutics, Inc. (CTY) stock is approximately US$956.31M.
The 52-week high for City Therapeutics, Inc. (CTY) stock is US$23.88.
The 52-week low for City Therapeutics, Inc. (CTY) stock is US$19.00.
City Therapeutics, Inc. (CTY) does not currently pay a dividend.
Stay on top of CTY
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
